The optimization of methadone dosing whilst treating with Rifampicin (cas 13292-46-1): A pharmacokinetic modeling study
-
Add time:07/18/2019 Source:sciencedirect.com
BackgroundThe use of oral methadone in opioid substitution treatment (OST) for the management of opioid use disorder is established clinical practice. Confounding treatment is the increased risks of contracting Mycobacterium tuberculosis, the mainstay treatment of which incorporates the potent CYP 2B6 inducer rifampicin.
We also recommend Trading Suppliers and Manufacturers of Rifampicin (cas 13292-46-1). Pls Click Website Link as below: cas 13292-46-1 suppliers
Prev:Evolution of Rifampicin (cas 13292-46-1) treatment for tuberculosis
Next:Attainment of target Rifampicin (cas 13292-46-1) concentrations in cerebrospinal fluid during treatment of tuberculous meningitis) - 【Back】【Close 】【Print】【Add to favorite 】